“Ortahaza failed on what could be simplified as flow rate issues. In conjunction with temperature, this is the primary mechanism behind viability.”
I would argue that GRK understands this better than anyone else in Australia. This is why they are working with CSIRO and I believe that their strategy will be revealed in due course.
“and there is no reason for GRK to warrant any more attention than URO or even TEY.”
I would suggest experience is the difference between the GRK and any other company. Even if they have GELs in prime locations with favourable stress fractures required for good flow rates.
“Ortahaza failed on what could be simplified as flow rate...
Add to My Watchlist
What is My Watchlist?